(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hept-6-enoic acid can be used for peptide synthesis and drug screening.
CAT No: Q-OS-0007
CAS No:1093645-21-6
Synonyms/Alias:1093645-21-6;(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hept-6-enoic acid;(R)-N-Fmoc-2-(4'-pentenyl)glycine;(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hept-6-enoic acid;(2R)-2-({[(9H-Fluoren-9-yl)methoxy]carbonyl}amino)hept-6-enoic acid;(2R)-2-{[(9H-fluoren-9-ylmethoxy)carbonyl]amino}hept-6-enoic Acid;(2R)-2-(Fmoc-amino)-6-heptenoic acid;(R)-N-Fmoc-2-(4-pentenyl)glycine;MFCD17215632;SCHEMBL1272388;DTXSID90736124;LRSIYGFZZWFAAI-HXUWFJFHSA-N;AKOS016005234;DS-3995;HY-W048180;AC-27583;CS-0100562;F12079;EN300-1556119;(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hept-6-enoicacid;(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)hept-6-enoic acid (Fmoc-D-Nva(Vinyl)-OH);
Chemical Name:(2R)-2-(9H-fluoren-9-ylmethoxycarbonylamino)hept-6-enoic acid
1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
2. Implications of ligand-receptor binding kinetics on GLP-1R signalling
3. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
4. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.